General
As of the end of August 2022, national sentinel surveillance sites for respiratory pathogens are reporting increases in pediatric hospitalizations of patients with severe respiratory illness who also tested positive for rhinovirus (RV) and/or enterovirus (EV).
RV-EV Respiratory Illness
Reccomendations for HAN Flu Vaccinations
On August 31, 2022, the FDA authorized emergency use of new bivalent formulations of both the Moderna COVID-19 and the Pfizer-BioNTech COVID-19 Vaccines for use as a single booster dose at least two months following primary or booster vaccination.